A deep-learning model combining radiomics and clinicopathologic data with breast DCE-MRI improves prediction of complete pathological response after chemotherapy.
Key Details
- 1Study led by Chaowei Wu, PhD, at Cedars-Sinai Medical Center.
- 2Model integrates clinicopathologic data, shape radiomics, and retrospective pharmacokinetic quantification radiomics.
- 3Included MRI data from 1,073 breast cancer patients (2002–2016).
- 4Model achieved higher AUCs (up to 0.82 on external datasets) vs. conventional methods.
- 5Reported accuracy 69%, sensitivity 95%, specificity 59%.
- 6Early pCR prediction aids personalized treatment planning.
Why It Matters
Improved prediction of chemotherapy response using AI-driven analysis of DCE-MRI could enable more personalized and effective treatment strategies in breast cancer, potentially improving outcomes. The results show better accuracy and generalizability than existing methods across multiple datasets.
Source
AuntMinnie
Related News
•Radiology Business
AI-Powered Tool Streamlines CT Scan Prioritization in Emergency Departments
An AI-based CT queue system significantly reduces wait times for ED patients by prioritizing scans likely to reveal critical findings.
•Radiology Business
AI Workflow Enables General Radiologists to Match Breast Specialists in Screening
AI-powered workflow helps generalist radiologists detect breast cancer at rates comparable to specialists.
•Radiology Business
LLMs Automate Radiology Report Quality Control, Study Finds
LLM-based systems can rapidly automate radiology report quality control, saving significant manual review time.